NCT02760251View on ClinicalTrials.gov

Immunomodulation With Romiplostim in Young Adults With ITP

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

July 31, 2019

Study Completion Date

March 31, 2020

Conditions
Immune Thrombocytopenia
Interventions
DRUG

romiplostim

Trial Locations (5)

4000

University Hospital Basel, Basel

Unknown

Liestal Cantonal Hospital, Liestal

Lucerne Cantonal Hospital, Lucerne

Aarau Cantonal Hospital, Aarau

University Hospital Bern, Bern

All Listed Sponsors
collaborator

University Children's Hospital Basel

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT02760251 - Immunomodulation With Romiplostim in Young Adults With ITP | Biotech Hunter | Biotech Hunter